Estrogen Replacement TherapyHormone Replacement TherapyPostmenopauseProgestinsMenopauseNorethindroneClimactericEstrogensRenal Replacement TherapyMedroxyprogesterone AcetateEstrogens, Conjugated (USP)NorpregnenesEnzyme Replacement TherapyEstradiolAdministration, CutaneousOsteoporosis, PostmenopausalOvariectomyProgesterone CongenersMenopause, PrematureHormonesRisk FactorsGonadal Steroid HormonesHuman Growth HormoneHysterectomyBreast NeoplasmsHypopituitarismHypothyroidismProgesteroneHot FlashesContraceptives, OralEquileninWomen's HealthMedroxyprogesteroneEstriolDydrogesteroneFollicle Stimulating HormoneThyroid HormonesThyroxineBone DensityUterine HemorrhageContraceptives, Oral, HormonalPerimenopauseTime FactorsProspective StudiesCase-Control StudiesPremenopauseEquilinEndometrial NeoplasmsCohort StudiesOsteoporosisLuteinizing HormoneEndometriumSelective Estrogen Receptor ModulatorsAge FactorsMedrogestoneTestosteroneEndometrial HyperplasiaReceptors, EstrogenIncidenceWomenCardiovascular DiseasesTurner SyndromeMammographyFollow-Up StudiesMenstrual CyclePhytoestrogensTreatment OutcomeRiskRandomized Controlled Trials as Topicalpha-GalactosidaseParathyroid HormoneMyxedemaReceptors, ProgesteroneEstroneOdds RatioRisk AssessmentThyrotropinCimicifugaRaloxifeneMixed Tumor, MesodermalRetrospective StudiesDouble-Blind MethodAmenorrheaUterusBody Mass IndexCohort EffectEstrogen Receptor ModulatorsGonadotropin-Releasing HormoneFabry DiseaseCross-Sectional StudiesBreastReproductive HistoryAcute Kidney InjuryQuestionnairesNandroloneSex Hormone-Binding GlobulinAdministration, OralHemostasisSmokingGrowth Disorders